Harvard Medical School Harvard Medical SchoolMain Menu
home contact search sitemap division site
mission people public info research education policy clinical care

Osher image
 

ACTIVE RESEARCH STUDIES

The research activities of the Division focus on four broad substantive areas which have considerable overlap but have naturally evolved as a result of our previous research findings, as well as the background and expertise of our core faculty. These areas include:

Acupuncture Research
The primary goal of these studies is to develop the appropriate methodology for evaluating this modality in order to evaluate efficacy, safety, and mechanisms of action within the context of a variety of clinical conditions.

Placebo Research
The primary goal for these studies is to develop a research and scholarly agenda concerning placebo effects and controls in research methodology. The research questions focus on all aspects of placebo, including the extent of the effect in any particular disease, whether the effect can be modulated, the components of the placebo response, the basic physiological and psychological mechanisms, and whether or not some individuals repeatedly show a placebo response.

Botanical Research
This is the newest area in which the Division will be focusing, but one which is the closest to the model of the new NIH roadmap in which inter-institutional and cross-disciplinary investigators will work together to facilitate fundamental discovery and translate that knowledge into effective preventive and therapeutic strategies. Our work to date has concentrated on utilizing collaborative local and international partnerships to identify and prioritize promising herbal medicines wich can be systematically procured, extracted, characterized, and subsequently tested in pre-clinical settings. Ultimately, the most successful of these will be tested in multi-site clinical trials.

Health Services Research
The primary aim of these studies is to examine directly the clinical and cost-effectivess of individual or multi-therapy interventions in the treatment of well-defined clinical populations (e.g., adults with low-back pain).

Acupuncture

RO1 AT001414
Acupuncture for Irritable Bowel Syndrome (Kaptchuk)
04/01/03-12/31/06

Little is known about acupuncture's efficacy for Irritable Bowel Syndrome (IBS). This trial uses a manualized acupuncture treatment format that closely follows clinical practice and allows flexibility in designing individualized treatments. In addition, a second parallel qualitative study will follow a subgroup of patients throughout the trial to explore the relationships between patients' interpretations and understandings (what anthropologists call "meaning") of irritable bowel and their response to treatment. Cortisol levels (an important stress hormone) will also be assessed. This will be a 3-arm trial: Active acupuncture, placebo acupuncture, and wait list.

Status: Recruitment initiated.

Key Personnel
Affiliation
Ted Kaptchuk, OMD (PI) Harvard Medical School Osher Research Center
Roger Davis, ScD Beth Israel Deaconess Medical Center
Eric Jacobson, PhD Harvard Medical School-Social Medicine
Catherine Kerr, PhD Harvard Medical School-Social Medicine
Irving Kirsch, PhD University of Connecticut
Elvira Lang, MD Beth Israel Deaconess Medical Center
Anna Legedza, ScD Beth Israel Deaconess Medical Center
Anthony Lembo, MD Beth Israel Deaconess Medical Center
William Stason, MD Harvard School of Public Health


U19 AT002022
NESA Acupuncture Research Collaborative (Buring)
9/25/03-12/31/06

As a Developmental Center for Research in Complementary and Alternative Medicine (DCRC), this grant brings together leaders from the oriental medicine (OM) and conventional medicine communities to evaluate critically the efficacy and safety of acupuncture, and develop sound methodologies and feasible study designs required for Asian Medicine research. This project strengthens and builds upon ongoing collaborations between the New England School of Acupuncture (NESA), the Harvard Medical School Division and Research Center, and two other HMS-affiliated institutions, the Dana Farber Cancer Institute and Children’s Hospital Boston. The DCRC involves three developmental/exploratory studies (two of which focus on acupuncture for treatment of women’s health issues) and two infrastructure cores (Administrative and Clinical Trials).

Status: Projects initiated. Protocols finalized and IRB applications in progress. Recruitment to begin 6/04.

Key Personnel
Affiliation
Peter Wayne, PhD (PI) New England School of Acupuncture
Julie Buring, ScD (HMS PI) Harvard Medical School Osher Research Center
Sally Andrews, MBA Harvard Medical School Osher Research Center
Lisa Conboy, ScD Harvard Medical School Osher Research Center
Ellen Connors MA New England School of Acupuncture
Roger Davis, ScD Beth Israel Deaconess Medical Center
Elizabeth Dean-Clower, MD Dana-Farber Cancer Institute
Anne Doherty, MPH Dana-Farber Cancer Institute
James Griffin, MD Dana-Farber Cancer Institute
Andrea Hrbek Harvard Medical School Osher Research Center
Ted Kaptchuk, OMD Harvard Medical School Osher Research Center
Catherine Kerr, PhD Harvard Medical School-Social Medicine
Alice Kornblith, PhD Dana-Farber Cancer Institute
Marc Laufer, MD Children’s Hospital Boston
Hang Lee, PhD Dana-Farber Cancer Institute
Anna Legedza, ScD Beth Israel Deaconess Medical Center
Zhi Ping Li, MB, MA New England School of Acupuncture
Weidong Lu, MB, MPH New England School of Acupuncture
Ursula Matulonis, MD Dana-Farber Cancer Institute
Patrick McKnight, PhD New England School of Acupuncture
Richard Penson, MD Dana-Farber Cancer Institute
David Rosenthal, MD Dana-Farber Cancer Institute
Steven Schachter, MD Harvard Medical School Osher Research Center
Rosa Schnyer, Dipl. Ac. New England School of Acupuncture
Edward Thomas, MBA New England School of Acupuncture

Botanicals

Starr Foundation
Evaluating East Asian Herbs for Their Chemo-preventive, Chemo-therapeutic Potential (Eisenberg)
11/1/03 - 05/31/06

This project tests a research strategy and protocols for the purchase, extraction, fractionation, and characterization of compounds with potential chemo-therapeutic and chemo-preventive properties. The results from this study will provide pilot data and procedures to be used in an NIH program project or specialized center of research grant (P-50).

Status: Forty-five herbs have been extracted and fractionated and are currently undergoing high throughput bioassay screening within the ICCB at HMS.

Key Personnel
Affiliation
David Eisenberg, MD (PI) Harvard Medical School Osher Research Center
Jon Clardy, PhD Harvard Medical School-Biological Chemistry & Molecular Pharmacology
Ted J. Kaptchuk, OMD Harvard Medical School Osher Research Center
Steven Schachter, MD Harvard Medical School Osher Research Center
David Lee, PhD McLean Hospital

The Epilepsy Cure (Fndtn)
Asian Herbs for Epilepsy (Schachter)
3/1/04-2/28/05

The specific aims of this grant are to: 1) systematically procure, extract, and characterize herbal medicines identified as promising for epilepsy; 2) to test these well-characterized herb extractions in validated animal models of epilepsy, and 3) to submit those herb extractions with anti-seizure properties (as demonstrated by the animal studies) to high-throughput screening to evaluate for biological activity.

Status: Testing in completed and analysis is ongoing.

Key Personnel
Affiliation
Steven Schachter, MD (PI) Harvard Medical School Osher Research Center
David Eisenberg, MD Harvard Medical School Osher Research Center
Julie Buring, ScD Harvard Medical School Osher Research Center
Michael Cohen, JD Harvard Medical School Osher Research Center
David Lee, PhD McLean Hospital
Jon Clardy, PhD

Harvard Medical School-Biological Chemistry & Molecular Pharmacology


Health Services and Clinical Trials

R21 AT002564
Patient Variables and Placebo Response in IBS (Ablon)
9/01/05-7/31/07

Research on whether patient psychological and personality variables can predict placebo response has been inconclusive and contradictory. Part of the problem in identifying and validating these patient variables arises out of the methods used to assess them. In particular, prior investigations have assessed these variables in isolation from the patient-practitioner relationship, often via self-report personality questionnaires taken at baseline. The approach in this study is unique in that we will study patient variables not in isolation but rather in context, as they manifest themselves during a clinical encounter. We hypothesize that the important patient factors influencing placebo response are not to be found in global measures of personality in general nor in attitude measures collected just prior to treatment, but rather in specific measures of the interpersonal process that occurs between a particular patient and a particular practitioner at a particular point in time.

Status: This study will use data generated in an earlier trial which has just completed recruitment.

Key Personnel
Affiliation
Stuart Ablon, PhD Massachusetts General Hospital
Lisa Conboy, ScD Harvard Medical School Osher Research Center
Ted Kaptchuk, OMD

Harvard Medical School Osher Research Center

John Kelly, PhD Massachusetts General Hospital

 

R01 AT002454
Tai Chi Mind-Body Therapy for Chronic Heart Failure (Yeh)
9/29/04-6/30/07

This study will examine Tai Chi, a meditative mind-body exercise form that has not yet been rigorously studied in patients with heart failure despite increasing popularity among the general public. Exercise has only recently been recognized as an important component of conventional HF management. Optimal protocols have not yet been defined in this population. Existing clinical trials focus solely on physical exercise that has no mindful component, such as treadmill or bicycle training. Tai Chi, however, may have advantages over conventional exercise forms and be particularly suited to frail, de-conditioned patients. With origins in Chinese healing and martial arts, Tai Chi incorporates both slow, gentle physical activity with meditation, relaxation and self-awareness and can be easily performed by chronically ill individuals with HF.

The primary goal of our proposed research is to determine the potential benefit of a tailored 12-week Tai Chi exercise program on functional capacity and health related quality-of-life in patients with chronic HF. The overarching secondary goal is to begin to understand the mechanisms underlying any beneficial effect of Tai Chi. Through exploration of various physiologic and metabolic pathways and behavioral/ psychosocial indices, we will be in a better position to design future mechanistic studies. In addition, this study will provide necessary data to analyze the cost implications for Tai Chi as adjunctive therapy for HF.

Status: Study has just started recruitment.

Key Personnel
Affiliation
Russel Phillips, MD Beth Israel Deaconess Medical Center
Gloria Yeh, MD, MPH Harvard Medical School Osher Research Center
David Eisenberg, MD

Harvard Medical School Osher Research Center

Roger Davis ScD Beth Israel Deaconess Medical Center
Ted Kaptchuk, OMD Harvard Medical School Osher Research Center


R01 AT00905
Model of Integrative Care in an Academic Health Center
(Eisenberg)
9/25/01-6/30/06

The purpose of this application is to develop a replicable model of integrative care within an academic medical center in order to plan subsequent controlled trials. It is intended to serve as a prototype to be refined and replicated at other hospitals regionally and nationally. The four aims of the project include:

1. Development of strategies procedures (i.e. credentialing, liability, pharmacy and therapeutics guidelines, data tracking, billing, administrative requirements) necessary to open an integrative care center within an academic health center.
2. To implement and refine these strategies in the operation of an integrative care clinical facility within an academic health center (BWH);
3. To demonstrate our ability to evaluate the effectiveness of care provided by the Integrative Care Center in a pilot RCT involving subjects with persistent low back pain;
4. To review the results of our pilot study to design a subsequent full-scale trial with adequate statistical power; to summarize the cost of building and sustaining this model; and, to document our strategies and disseminate our procedures, enabling transfer and refinement of the model at other sites.

Status: Policies and procedures have been developed. A hospital partner has been identified (i.e. BWH). The clinician team has been identified and has participated in training over the last eight months. An RCT (n=60) has been designed and approved by the Partner’s IRB and has been initiated.

Key Personnel
Affiliation
David Eisenberg, MD (PI) Harvard Medical School Osher Research Center
Ted Kaptchuk, OMD Harvard Medical School Osher Research Center
Michael Cohen, JD

Harvard Medical School Osher Research Center

Russ Phillips, MD Beth Israel Deaconess Medical Center
Maureen Connelly, MD Harvard Pilgrim/Harvard Vanguard
Roger Davis, ScD

Beth Israel Deaconess Medical Center

Andrea Hrbek, BA Harvard Medical School Osher Research Center
Donald Levy, MD Harvard Medical School Osher Research Center
Sally Andrews, MBA Harvard Medical School Osher Research Center
Mark Cunningham Harvard Medical School Osher Research Center



1R21 CA098487
Massage for Hospitalized Patients with Metastatic Cancer
4/1/04-3/31/06

Symptoms such as pain and nausea are common among patients with metastatic cancer, and symptom control is often inadequate. Massage therapy has been advocated as adjunctive therapy in the management of cancer related pain, but has received little careful study. Our study will enroll 100 patients admitted to the hospital with metastatic cancer and randomize them to receive massage therapy, a sham massage control, or usual care while in the hospital. Following completion of the hospital-based data collection, half of subjects with caregivers will be randomized to receive instruction to enable caregivers to provide massage for patients at home. We will collect data from patients and caregivers to determine the impact of hospital-based massage therapy and home-based caregiver massage on cancer-related symptoms and quality of life.

Status: Study is in recruitment.

Key Personnel
Affiliation
Russel Phillips, MD Beth Israel Deaconess Medical Center
Janet Kahn, LMT, PhD Peace Village Projects
Roger Davis ScD Beth Israel Deaconess Medical Center

 

Education

T32 AT000051
Research Training: Complementary and Integrative Medicine (Phillips)
9/30/99-7/31/09

In 2003 Harvard Medical School's NIH fellowship training grant for training in integrative medicine was renewed for a second five-year term. Although academic centers devoted to CAM research have been funded, there is a shortage of trained clinical investigators with interest and expertise in CAM modalities. Therefore, NIH-funding training programs are required to prepare trainees for research careers in the field. This program is the first post-doctoral fellowship in CAM research to be based at Harvard MedicalSchool. The program has graduated sex MD Fellows to date, all of whom have moved on to research positions at academic centers or positions combining clinical and research training.

Key Personnel
Affiliation
Russel Phillips, MD Beth Israel Deaconess Medical Center
Sally Andrews, MBA Harvard Medical School Osher Research Center
David Eisenberg, MD

Harvard Medical School Osher Research Center

Roger Davis ScD Beth Israel Deaconess Medical Center


K23 AT002624
BioMind-Body Exercise in the Management of Cardiac Disease (Yeh)
2/01/05-1/31/10

This career development award Dr. Yeh in acquiring additional research skills and experience under the mentorship of nationally and internationally known researchers in a supportive academic environment. Collectively, the three related projects in this proposal will allow her to further focus her research efforts on cardiovascular disease and complementary therapies.

Key Personnel
Affiliation
Gloria Yeh, MD, MPH Harvard Medical School Osher Research Center
Russel Phillips, MD Beth Israel Deaconess Medical Center
Julie Buring, ScD

Brigham and Women's Hospital

Ari Goldberger, MD Beth Israel Deaconess Medical Center
David Eisenberg, MD Harvard Medical School Osher Research Center
Ted Kaptchuk, OMD Harvard Medical School Osher Research Center


K23 AT003238
Biophysics of Acupuncture: Electrical Properties of Loose CT (Ahn)
9/30/05-9/29/10

This career development proposal supports a long-term inquiry in the biophysical nature of acupuncture meridians and points. This proposal is driven by the hypothesis that electrical signals through loose connective tissue are responsible for communications occurring in the acupuncture network. Recent studies have shown that acupuncture meridians correspond to connective tissue planes. While the anatomical correlation has been made, the physiological significance of this association is unclear. Elucidating the mechanisms underlying these properties may greatly enhance our understanding of acupuncture’s clinical effects.

Key Personnel
Affiliation
Andrew Ahn, MD, MPH Harvard Medical School Osher Research Center
Russel Phillips, MD Beth Israel Deaconess Medical Center
Alan Grodinsky, ScD

Massachusetts Institute of Technology

Helene Langevin, MD University of Vermont Medical School
Ted Kaptchuk, OMD Harvard Medical School Osher Research Center

 

Completed Studies

RO1 AT00622
Physical CAM Therapies for Chronic Low Back Pain
(Eisenberg)
9/1/00-6/30/04

This study evaluates the relative effectiveness and costs of the three most commonly used physical CAM therapies (acupuncture, chiropractic, and massage) for both older and younger adults with chronic low back pain. Phase I involved testing and refining the components of a randomized clinical trial evaluating acupuncture, chiropractic and massage for chronic low back pain including specification of treatment and comparison groups, subject selection criteria, recruitment and retention strategies, and development of instruments for measuring outcomes. During Phase II, a pilot study, using the findings from Phase I, was conducted to evaluate the three physical CAM treatments. Results of the pilot study will be used to identify unanticipated problems and to estimate the sample sizes required for an adequately powered full-scale trial.

Status: Study complete. Analysis is ongoing.

Key Personnel
Affiliation
David Eisenberg, MD Harvard Medical School Osher Research Center
Ted Kaptchuk, OMD Harvard Medical School Osher Research Center
Dan Cherkin, PhD

Group Health Cooperative of Puget Sound

Roger Davis ScD Beth Israel Deaconess Medical Center
Maureen Connelly, MD, MPH Harvard Pilgrim/Harvard Vanguard
Karen Sherman, PhD

Group Health Cooperative

RO1 AT00607
Optimizing Therapeutic Ratios for Herbs (Goldman)
9/1/00-6/30/05

The goal of this proposal is to investigate whether ginkgo may interact with such prescribed anticoagulants as warfarin and ticlopidine at the level of the cytochrome P450 system. Additional studies will determine which fractions of ginkgo are responsible for its anti-platelet effects and how these fractions relate to ginkgo’s non-specific antioxidant effects, which many believe are responsible for ginkgo’s benefits. By addressing the issues of herbal product consistency and using laboratory models to define chemical and biological mechanisms of potential clinical significance, this proposal offers a paradigm for the multidisciplinary study of commonly used herbal products.

Status: This project is completed and papers are now being authored.

Key Personnel
Affiliation
Peter Goldman, MD (PI) Harvard Medical School Osher Research Center
Ted Kaptchuk, OMD (PI) Harvard Medical School Osher Research Center
Ikhlas Khan, PhD University of Mississippi
David Greenblatt, MD Tufts University School of Medicine

R21 AT001979-01
US-China-Japan Research Consortium on Herbal Medicines
(Eisenberg)
09/25/03 - 03/31/05

This planning grant has the long-term goal of developing an International Center for CAM Research focused on the systematic evaluation of East Asian herbal medicines.

Status: Regular conference calls are held among consortium members to: 1) prioritize top candidate herbs; 2) develop/refine existing protocols to Perform Bioassays/HST evaluations; 3) plan for the Phase II grant submission and clinical trial development.

Key Personnel
Affiliation
David Eisenberg, MD (PI) Harvard Medical School Osher Research Center
Julie Buring, ScD Harvard Medical School Osher Research Center
Paul Hays But, PhD Chinese University of Hong Kong
Ke-Ji Chen, MD China Academy of Traditional Chinese Medicine
Jon Clardy, PhD Harvard Medical School-Biological Chemistry & Molecular Pharmacology
Michael Cohen, JD Harvard Medical School Osher Research Center
James Feinerman, MD Georgetown University School of Law
Sherman Kowk-Wing Fung, PhD Chinese University of Hong Kong
Saishan Guo, MD Chinese Academy of Medical Sciences
Ted Kaptchuk, OMD Harvard Medical School Osher Research Center
P.C. Leung, MD Chinese University of Hong Kong
Gregg Plotnikoff, PhD Keio University
Han Rui, MD Chinese Academy of Medicine
Steven Schachter, MD Harvard Medical School Osher Research Center
Catherine E Shamu, PhD Harvard Medical School
Jun Song, MD China Academy of Traditional Chinese Medicine
Kenji Watanabe, MD, PhD Keio University

RO1 AT001414
Usual Care Vs Choice of Alternative Rx: Low Back Pain (Eisenberg)
9/30/99-8/31/03

This study compares two approaches to the management of acute low back pain: usual care (standard benefit) vs. the choice of: usual care, chiropractic, acupuncture or massage therapy (expanded benefit). The results of this randomized trial of 44 subjects will provide valuable information to clinicians, patients and third party payers on the relative benefits and costs of an "expanded benefits" treatment option which incorporates chiropractic, acupuncture and massage services for low back pain.

Status: Study complete. Analysis is ongoing.

Key Personnel
Affiliation
David Eisenberg, MD Harvard Medical School Osher Research Center
Ted Kaptchuk, OMD Harvard Medical School Osher Research Center
Russell Phillips, MD Beth Israel Deaconess Medical Center
Roger Davis ScD Beth Israel Deaconess Medical Center
Maureen Connelly, MD, MPH Harvard Pilgrim/Harvard Vanguard
Dan Cherkin, PhD

Group Health Cooperative of Puget Sound

Diana Post, MD Brigham and Women's Hospital
Anna Legedza, ScD Harvard Medical School Osher Research Center
Julie Buring, ScD Harvard Medical School Osher Research Center
Andrea Hrbek, BA Harvard Medical School Osher Research Center
Lisa Prosser, PhD Harvard Pilgrim/Harvard Vanguard

G13 LM07575 (NLM)
Legal and Social Barriers to Alternative Medicine
(Cohen)
1/15/02-12/31/04

The project will result in a scholarly, book-length manuscript that critically evaluates the integration of complementary and alternative medical (“CAM”) therapies into conventional medical settings in the United States. Methods have included a critical review of literature and interviews with key personnel in existing, integrated health care centers, regarding the development of their practices and the problems they have encountered. Such a study aims to fill a gap in the current health care literature by collecting the kind of information needed to develop, sustain and evaluate critically the evidence-based clinical integration of CAM therapies in conventional medical settings.

Status: Interviews completed. Draft book manuscript in process.

Key Personnel
Affiliation
Michael Cohen, JD (PI) Harvard Medical School Osher Research Center
Mary Ruggie, PhD Harvard University-Kennedy School of Government
David Eisenberg, MD Harvard Medical School Osher Research Center
Ted Kaptchuk, OMD Harvard Medical School Osher Research Center

RO1 AT00402
Sham Device, Pill Placebo Or Treatment For Arm Pain (Kaptchuk)
09/01/00-06/30/04
Status: Recruitment and data collection completed. Analysis is ongoing. A draft manuscript has been submitted.

Key Personnel Affiliation
Ted Kaptchuk, OMD (PI) Harvard Medical School Osher Research Center
Rose Goldman, MD Cambridge Health Alliance
William Stason, MD Harvard School of Public Health
Roger Davis, ScD Beth Israel Deaconess Medical Center
 

Copyright 2005 by the President and Fellows of Harvard College
Liability Statement